Enveric Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $340 | $0 |
Gross Profit | -39 | -81 | 170 | -84 |
EBITDA | -2,479 | -2,106 | -3,091 | -1,998 |
EBIT | -2,519 | -2,187 | -3,173 | -2,083 |
Net Income | -2,519 | -2,184 | -3,154 | -2,084 |
Net Change In Cash | 0 | 0 | 340 | 0 |
Free Cash Flow | -1,890 | -2,391 | -1,311 | -927 |
Cash | 2,849 | 4,294 | 2,241 | 3,111 |
Basic Shares | 2,595 | 1 | 654 | 1,406 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -337 | -408 | -435 | -681 |
EBITDA | -9,228 | -16,854 | -19,516 | -63,966 |
EBIT | -9,566 | -17,262 | -19,952 | -64,648 |
Net Income | -9,574 | -17 | -18,471 | -48,976 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,726 | -14,099 | -17,730 | -12,322 |
Cash | 2,241 | 2,287 | 17,723 | 17,356 |
Basic Shares | 502 | 2,159 | 2,078 | 472 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.97 |
2025-03-31 | -$4.81 |
2024-12-31 | -$0.17 |
2024-09-30 | -$3.60 |
